4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-008365
Options or other derivatives
- Chief Financial Officer acquired 247,841 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stanker James H Chief Financial Officer | 2022-04-01 | Grant or award · Restricted Stock Units | −247,841 | 302,766 | D | ||
Loading xslF345X03/doc1.xml…